CompletedNot Applicable

Cross Cultural Validation of the Italian Version of the Clinical Assessment of Dysphagia in Neurodegeneration

Italy101 participantsStarted 2022-04-05

Plain-language summary

The English version of the "Clinical Assessment of Dysphagia in Neurodegeneration" (CADN), represents a rapid and valid clinical assessment tool for dysphagia in neurodegenerative population. Currently, there is no validated tool in Italian specific for the clinical assessment of dysphagia in neurodegenerative disease with strong psychometric characteristics. The present study aims to translate and validate the Italian version of CADN in neurodegenerative population. Psychometric properties will be measured.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * diagnosis of neurodegenerative disease according to the respective consensus criteria * \>18 years old * able to provide informed consent * able to follow simple instructions * capable of sitting upright for anamnesis and examination for at least 20 min (in chair or wheelchair) Exclusion Criteria: * history of stroke * surgery to the head or neck * radiotherapy in the last 12 months * dysphagia resulting from other known causes

What they're measuring

Clinical Assessment of Dysphagia in Neurodegeneration (CADN)

Timeframe: at the enrolment

Clinical Assessment of Dysphagia in Neurodegeneration (CADN)

Timeframe: at 24 hours from enrolment

Trial details

NCT IDNCT05733494

SponsorIstituti Clinici Scientifici Maugeri SpA

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-02-16

View on ClinicalTrials.gov More Swallowing Disorder trials